Hyphens Pharma International Ltd.’s (1J5) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Hyphens Pharma International Ltd. is a Buy.

Hyphens Pharma International Ltd.’s (1J5) 20-Day exponential moving average is 0.28, while Hyphens Pharma International Ltd.’s (1J5) share price is S$0.28, making it a Sell.

Hyphens Pharma International Ltd.’s (1J5) 50-Day exponential moving average is 0.28, while Hyphens Pharma International Ltd.’s (1J5) share price is S$0.28, making it a Sell.

Hyphens Pharma International Ltd. (1J5) Pivot Points

Jan 30, 2025, 05:24 PM

Classic

0.28

Fibonacci

0.28

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Hyphens Pharma International Ltd. (1J5) Moving Averages

Jan 30, 2025, 05:24 PM

MA5

0.28Sell

MA10

0.28Sell

MA20

0.28Sell

MA50

0.28Sell

MA100

0.29Sell

0.28Sell

MA200

0.28Sell

Hyphens Pharma International Ltd.’s (1J5) 10-Day exponential moving average is 0.28, while Hyphens Pharma International Ltd.’s (1J5) share price is S$0.28, making it a Sell.

Hyphens Pharma International Ltd.’s (1J5) 100-Day exponential moving average is 0.28, while Hyphens Pharma International Ltd.’s (1J5) share price is S$0.28, making it a Sell.

Hyphens Pharma International Ltd.’s (1J5) stock price is S$0.28 and Hyphens Pharma International Ltd.’s (1J5) 50-day simple moving average is 0.28, creating a Sell signal.

Hyphens Pharma International Ltd.’s (1J5) stock price is S$0.28 and Hyphens Pharma International Ltd.’s (1J5) 100-day simple moving average is 0.29, creating a Sell signal.

Hyphens Pharma International Ltd.’s (1J5) stock price is S$0.28 and Hyphens Pharma International Ltd.’s (1J5) 200-day simple moving average is 0.28, creating a Sell signal.

Hyphens Pharma International Ltd. (1J5) Technical Indicators

Jan 30, 2025, 05:24 PM

RSI (14)

46.19

Neutral

STOCH (9,6)

33.33

Neutral

STOCHRSI (14)

33.33

Neutral

MACD (12,26)

>-0.01

Buy

ADX (14)

15.01

Buy

Williams %R

-100.00

Buy

CCI (14)

-90.91

Neutral

ATR (14)

<0.01

Ultimate Oscillator

14.57

Sell

ROC

-3.45

Sell

Hyphens Pharma International Ltd.’s (1J5) Relative Strength Index (RSI) is 46.19, creating a Neutral signal.

Hyphens Pharma International Ltd.’s (1J5) Trend Strength Indicator (ADX) is 15.01, creating a Buy signal.

Hyphens Pharma International Ltd.’s (1J5) Commodity Channel Index (CCI) is -90.91, creating a Neutral signal.

Hyphens Pharma International Ltd.’s (1J5) Price Rate of Change (ROC) is -3.45, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is 1J5 a Buy, Hold, or Sell?

Based on 1J5’s technical indicators, 1J5 is a Sell.

What is 1J5’s RSI (14)?

1J5’s RSI (14) is 46.19, which suggests 1J5 is a Neutral.

What is 1J5’s MACD?

1J5’s MACD is >-0.01, which suggests 1J5 is a Buy.

What is 1J5’s 5-day moving average?

1J5’s 5-day moving average is 0.28, which suggests 1J5 is a Sell.

What is 1J5’s 20-day moving average?

1J5 20-day moving average is 0.28, which suggests 1J5 is a Sell.

What is 1J5’s 50-day moving average?

1J5’s 50-day moving average is 0.28, which suggests 1J5 is a Sell.

What is 1J5’s 200-day moving average?

1J5’s 200-day moving average is 0.28, which suggests 1J5 is a Sell.

What is 1J5’s Williams % R (14)?

1J5’s Williams % R (14) is -100.00, which suggests 1J5 is a Buy.

What is 1J5’s CCI (14)?

1J5’s CCI (14) is -90.91, which suggests 1J5 is a Neutral.

What is the share price of Hyphens Pharma International Ltd.?

Hyphens Pharma International Ltd.'s share price is N/AS$.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing